425 related articles for article (PubMed ID: 19843243)
21. Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome.
Singh MK; Singh L; Chosdol K; Pushker N; Saini N; Meel R; Bakhshi S; Sen S; Kashyap S
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2969-2982. PubMed ID: 31612319
[TBL] [Abstract][Full Text] [Related]
22. Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.
Manarang JC; Otteson DC; McDermott AM
Curr Eye Res; 2017 Nov; 42(11):1474-1481. PubMed ID: 28910167
[TBL] [Abstract][Full Text] [Related]
23. [Cytokines in uveal melanoma. Original title: uveal melanoma cytokines].
Filer RS; Song JC; Char DH; Kaleta-Michaels S
Klin Monbl Augenheilkd; 1993 Mar; 202(3):174-9. PubMed ID: 8510410
[TBL] [Abstract][Full Text] [Related]
24. Surveillance options for patients with uveal melanoma following definitive management.
Francis JH; Patel SP; Gombos DS; Carvajal RD
Am Soc Clin Oncol Educ Book; 2013; ():382-7. PubMed ID: 23714555
[TBL] [Abstract][Full Text] [Related]
25. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma.
Ophthalmic Oncology Task Force
Ophthalmology; 2016 Jan; 123(1):86-91. PubMed ID: 26505803
[TBL] [Abstract][Full Text] [Related]
26. A rational approach to the follow-up of melanoma patients.
Garbe C
Recent Results Cancer Res; 2002; 160():205-15. PubMed ID: 12079215
[TBL] [Abstract][Full Text] [Related]
27. Genes and regulatory pathways involved in persistence of dormant micro-tumors.
Almog N
Adv Exp Med Biol; 2013; 734():3-17. PubMed ID: 23143972
[TBL] [Abstract][Full Text] [Related]
28. Evolutionary Routes in Metastatic Uveal Melanomas Depend on
Rodrigues M; Mobuchon L; Houy A; Alsafadi S; Baulande S; Mariani O; Marande B; Ait Rais K; Van der Kooij MK; Kapiteijn E; Gassama S; Gardrat S; Barnhill RL; Servois V; Dendale R; Putterman M; Tick S; Piperno-Neumann S; Cassoux N; Pierron G; Waterfall JJ; Roman-Roman S; Mariani P; Stern MH
Clin Cancer Res; 2019 Sep; 25(18):5513-5524. PubMed ID: 31227496
[TBL] [Abstract][Full Text] [Related]
29. Melanoma dormancy in a mouse model is linked to GILZ/FOXO3A-dependent quiescence of disseminated stem-like cells.
Touil Y; Segard P; Ostyn P; Begard S; Aspord C; El Machhour R; Masselot B; Vandomme J; Flamenco P; Idziorek T; Figeac M; Formstecher P; Quesnel B; Polakowska R
Sci Rep; 2016 Jul; 6():30405. PubMed ID: 27465291
[TBL] [Abstract][Full Text] [Related]
30. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
[TBL] [Abstract][Full Text] [Related]
31. The biology and clinical implications of prostate cancer dormancy and metastasis.
Morrissey C; Vessella RL; Lange PH; Lam HM
J Mol Med (Berl); 2016 Mar; 94(3):259-65. PubMed ID: 26489605
[TBL] [Abstract][Full Text] [Related]
32. Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma.
Wan Q; Tang J; Han Y; Wang D
Exp Eye Res; 2018 Jan; 166():13-20. PubMed ID: 29031853
[TBL] [Abstract][Full Text] [Related]
33. Novel Approaches to the Systemic Management of Uveal Melanoma.
Khan S; Carvajal RD
Curr Oncol Rep; 2020 Jul; 22(10):104. PubMed ID: 32725406
[TBL] [Abstract][Full Text] [Related]
34. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P
PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791
[TBL] [Abstract][Full Text] [Related]
35. Targeting STAT3 affects melanoma on multiple fronts.
Kortylewski M; Jove R; Yu H
Cancer Metastasis Rev; 2005 Jun; 24(2):315-27. PubMed ID: 15986140
[TBL] [Abstract][Full Text] [Related]
36. Stromal changes in the aged lung induce an emergence from melanoma dormancy.
Fane ME; Chhabra Y; Alicea GM; Maranto DA; Douglass SM; Webster MR; Rebecca VW; Marino GE; Almeida F; Ecker BL; Zabransky DJ; Hüser L; Beer T; Tang HY; Kossenkov A; Herlyn M; Speicher DW; Xu W; Xu X; Jaffee EM; Aguirre-Ghiso JA; Weeraratna AT
Nature; 2022 Jun; 606(7913):396-405. PubMed ID: 35650435
[TBL] [Abstract][Full Text] [Related]
37. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
Martorano LM; Winkelmann RR; Cebulla CM; Abdel-Rahman MH; Campbell SM
Int J Dermatol; 2014 Jun; 53(6):657-63. PubMed ID: 24697775
[TBL] [Abstract][Full Text] [Related]
38. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
[No Abstract] [Full Text] [Related]
39. BRAF mutations are detectable in conjunctival but not uveal melanomas.
Spendlove HE; Damato BE; Humphreys J; Barker KT; Hiscott PS; Houlston RS
Melanoma Res; 2004 Dec; 14(6):449-52. PubMed ID: 15577314
[TBL] [Abstract][Full Text] [Related]
40. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns.
Folberg R; Arbieva Z; Moses J; Hayee A; Sandal T; Kadkol S; Lin AY; Valyi-Nagy K; Setty S; Leach L; Chévez-Barrios P; Larsen P; Majumdar D; Pe'er J; Maniotis AJ
Am J Pathol; 2006 Oct; 169(4):1376-89. PubMed ID: 17003493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
